Erratum: Vortioxetine disinhibits pyramidal cell function and enhances synaptic plasticity in the rat hippocampus (Journal of Psychopharmacology (2014) 28 (891-902) DOI:10.1177/0269881114543719);Vortioxetine disinhibits pyramidal cell function and enhances synaptic plasticity in the rat hippocampus

Journal of Psychopharmacology

Volumn 28, Issue 10, 2014, Pages 891-902

  Dale, Elena ^a   Zhang, Hong ^a   Leiser, Steven C ^a   Xiao, Yixin ^b   Lu, Dunguo ^b   Yang, Charles R ^b   Plath, Niels ^c   Sanchez, Connie ^a  

^a LUNDBECK RESEARCH USA   (United States)

^b Shanghai ChemPartner Co Ltd   (China)

^c H LUNDBECK A S   (Denmark)

Author keywords

5 hydroxytryptamine 3 receptor; CA1; Cognition; Electroencephalography; Long term potentiation; Serotonin

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; PIPERAZINE DERIVATIVE; SEROTONIN; SEROTONIN ANTAGONIST; SULFIDE; VORTIOXETINE;

ANIMAL; DRUG EFFECTS; FRONTAL LOBE; HIPPOCAMPAL CA1 REGION; INHIBITORY POSTSYNAPTIC POTENTIAL; NERVE CELL PLASTICITY; PHYSIOLOGY; PYRAMIDAL NERVE CELL; RAT; SYNAPTIC TRANSMISSION; THETA RHYTHM;

ANIMALS; ANTIDEPRESSIVE AGENTS; CA1 REGION, HIPPOCAMPAL; CITALOPRAM; FRONTAL LOBE; INHIBITORY POSTSYNAPTIC POTENTIALS; NEURONAL PLASTICITY; PIPERAZINES; PYRAMIDAL CELLS; RATS; SEROTONIN; SEROTONIN ANTAGONISTS; SULFIDES; SYNAPTIC TRANSMISSION; THETA RHYTHM;

EID: 84907506717     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881114560488     Document Type: Erratum

References (67)

1. Adell A (2010) Lu-AA21004, a multimodal serotonergic agent, for the potential treatment of depression and anxiety. IDrugs 13:900-910.
2. Alvarez E, Perez V, Dragheim M, et al. (2012) A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorder. Int J Neuropsychopharmacol 15:589-600.
3. Andrade R and Nicoll RA (1987) Pharmacologically distinct actions of serotonin on single pyramidal neurones of the rat hippocampus recorded in vitro. J Physiol 394:99-124.
4. Arai A and Lynch G (1992) Factors regulating the magnitude of longterm potentiation induced by theta pattern stimulation. Brain Res 598:173-184.
5. Arnsten AF, Lin CH, Van Dyck CH, et al. (1997) The effects of 5-HT3 receptor antagonists on cognitive performance in aged monkeys. Neurobiol Aging 18:21-28.
6. Bang-Andersen B, Ruhland T, Jorgensen M, et al. (2011) Discovery of 1-[2-(2, 4-dimethylphenylsulfanyl) phenyl]piperazine (Lu AA21004): A novel multimodal compound for the treatment of major depressive disorder. J Med Chem 54:3206-3221.
7. Basar E, Basar-Eroglu C, Karakas S, et al. (2000) Brain oscillations in perception and memory. Int J Psychophysiol 35:95-124.
8. Bastlund JF, Jennum P, Mohapel P, et al. (2004) Measurement of cortical and hippocampal epileptiform activity in freely moving rats by means of implantable radiotelemetry. J Neurosci Methods 138:65-72.
9. Beck SG, Clarke WP and Goldfarb J (1985) Spiperone differentiates multiple 5-hydroxytryptamine responses in rat hippocampal slices in vitro. Eur J Pharmacol 116:195-197.
10. Berger TW, Rinaldi PC, Weisz DJ, et al. (1983) Single-unit analysis of different hippocampal cell types during classical conditioning of rabbit nictitating membrane response. J Neurophysiol 50:1197-1219.
11. Brambilla A, Ghiorzi A, Pitsikas N, et al. (1993) DAU 6215, a novel 5-HT3-receptor antagonist, selectively antagonizes scopolamineinduced deficit in a passive-avoidance task, but not scopolamineinduced hypermotility in rats. J Pharm Pharmacol 45:841-843.
12. Buhot MC, Martin S and Segu L (2000) Role of serotonin in memory impairment. Ann Med 32:210-221.
13. Caplan JB, Madsen JR, Raghavachari S, et al. (2001) Distinct patterns of brain oscillations underlie two basic parameters of human maze learning. J Neurophysiol 86:368-380.
14. Chaput Y, Araneda RC and Andrade R (1990) Pharmacological and functional analysis of a novel serotonin receptor in the rat hippocampus. Eur J Pharmacol 182:441-456.
15. Chen L, Yung KK, Chan YS, et al. (2008) 5-HT excites globus pallidus neurons by multiple receptor mechanisms. Neuroscience 151:439-451.
16. Conradi HJ, Ormel J and De Jonge P (2011) Presence of individual (residual) symptoms during depressive episodes and periods of remission: A 3-year prospective study. Psychol Med 41:1165-1174.
17. Corradetti R, Ballerini L, Pugliese AM, et al. (1992) Serotonin blocks the long-term potentiation induced by primed burst stimulation in the CA1 region of rat hippocampal slices. Neuroscience 46:511-518.
18. Cowen P and Sherwood AC (2013) The role of serotonin in cognitive function: Evidence from recent studies and implications for understanding depression. J Psychopharmacol 27:575-583.
19. Deng PY and Lei S. (2008) Serotonin increases GABA release in rat entorhinal cortex by inhibiting interneuron TASK-3 K+ channels. Mol Cell Neurosci 39:273-284.
20. Dorostkar MM and Boehm S (2007) Opposite effects of presynaptic 5-HT3 receptor activation on spontaneous and action potentialevoked GABA release at hippocampal synapses. J Neurochem 100:395-405.
21. Du Jardin KG, Jensen JB, Sanchez C, et al. (2013) Vortioxetine dosedependently reverses 5-HT depletion-induced deficits in spatial working and object recognition memory: A potential role for 5-HT receptor agonism and 5-HT receptor antagonism. Eur Neuropsychopharmacol 24:160-171.
22. Fontana DJ, Daniels SE, Henderson C, et al. (1995) Ondansetron improves cognitive performance in the Morris water maze spatial navigation task. Psychopharmacology (Berl) 120:409-417.
23. Hong E and Meneses A (1996) Systemic injection of p-chloroamphetamine eliminates the effect of the 5-HT3 compounds on learning. Pharmacol Biochem Behav 53:765-769.
24. Horiguchi M, Huang M and Meltzer HY (2011) The role of 5-hydroxytryptamine 7 receptors in the phencyclidine-induced novel object recognition deficit in rats. J Pharmacol Exp Ther 338:605-614.
25. Horisawa T, Ishibashi T, Nishikawa H, et al. (2011) The effects of selective antagonists of serotonin 5-HT7 and 5-HT1A receptors on MK-801-induced impairment of learning and memory in the passive avoidance and Morris water maze tests in rats: Mechanistic implications for the beneficial effects of the novel atypical antipsychotic lurasidone. Behav Brain Res 220:83-90.
26. Jensen JB, Du Jardin KG, Song D, et al. (2013) Vortioxetine, but not escitalopram or duloxetine, reverses memory impairment induced by central 5-HT depletion in rats: Evidence for direct 5-HT receptor modulation. Eur Neuropsychopharmacol 24:148-159.
27. Katona C, Hansen T and Olsen CK (2012) A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder. Int Clin Psychopharmacol 27:215-223.
28. Kawa K (1994) Distribution and functional properties of 5-HT3 receptors in the rat hippocampal dentate gyrus: A patch-clamp study. J Neurophysiol 71:1935-1947.
29. Klimesch W (1999) EEG alpha and theta oscillations reflect cognitive and memory performance: A review and analysis. Brain Res Brain Res Rev 29:169-195.
30. Koyama S, Matsumoto N, Kubo C, et al. (2000) Presynaptic 5-HT3 receptor-mediated modulation of synaptic GABA release in the mechanically dissociated rat amygdala neurons. J Physiol 529:373-383.
31. Leiser SC, Pehrson AL, Robichaud PJ, et al. The multimodal antidepressant vortioxetine increases frontal cortical oscillations unlike escitalopram and duloxetine - a quantitative electroencephalographic study in the rat. Br J Pharmacol 2014 May 21. doi: 10.1111/bph.12782.
32. McClintock SM, Husain MM, Wisniewski SR, et al. (2011) Residual symptoms in depressed outpatients who respond by 50% but do not remit to antidepressant medication. J Clin Psychopharmacol 31:180-186.
33. McIntyre RS, Lophaven S and Olsen CK (2013) Randomized, doubleblind, placebo-controlled study of the efficacy of vortioxetine on cognitive dysfunction in adult patients with major depressive disorder (MDD) (abstract T160). Neuropsychopharmacology 38:S380-S381.
34. McLean SL, Woolley ML, Thomas D, et al. (2009) Role of 5-HT receptor mechanisms in sub-chronic PCP-induced reversal learning deficits in the rat. Psychopharmacology (Berl) 206:403-414.
35. McMahon LL and Kauer JA (1997) Hippocampal interneurons are excited via serotonin-gated ion channels. J Neurophysiol 78:2493-2502.
36. Maeda T, Kaneko S and Satoh M (1994) Inhibitory influence via 5-HT3 receptors on the induction of LTP in mossy fiber-CA3 system of guinea-pig hippocampal slices. Neurosci Res 18:277-282.
37. Maire M, Reichert CF and Schmidt C (2013) Sleep-wake rhythms and cognition. J Cogn Behav Psychother 13:133-170.
38. Meneses A (2003) A pharmacological analysis of an associative learning task: 5-HT (1) to 5-HT (7) receptor subtypes function on a Pavlovian/instrumental autoshaped memory. Learn Mem 10:363-372.
39. Millan MJ, Agid Y, Brune M, et al. (2012) Cognitive dysfunction in psychiatric disorders: Characteristics, causes and the quest for improved therapy. Nat Rev Drug Discov 11:141-168.
40. Mnie-Filali O, El Mansari M, Espana A, et al. (2006) Allosteric modulation of the effects of the 5-HT reuptake inhibitor escitalopram on the rat hippocampal synaptic plasticity. Neurosci Lett 395:23-27.
41. Monckton JE and McCormick DA (2002) Neuromodulatory role of serotonin in the ferret thalamus. J Neurophysiol 87:2124-2136.
42. Mørk A, Montezinho LP, Miller S, et al. (2013) Vortioxetine (Lu AA21004), a novel multimodal antidepressant, enhances memory in rats. Pharmacol Biochem Behav 105:41-50.
43. Mørk A, Pehrson A, Brennum LT, et al. (2012) Pharmacological effects of Lu AA21004: A novel multimodal compound for the treatment of major depressive disorder. J Pharmacol Exp Ther 340:666-675.
44. Otto T, Eichenbaum H, Wiener SI, et al. (1991) Learning-related patterns of CA1 spike trains parallel stimulation parameters optimal for inducing hippocampal long-term potentiation. Hippocampus 1:181-192.
45. Owens MJ, Knight DL and Nemeroff CB (2001) Second-generation SSRIs: Human monoamine transporter binding profile of escitalopram and R-fluoxetine. Biol Psychiatry 50:345-350.
46. Parmentier-Batteur S, O'Brien JA, Doran S, et al. (2012) Differential effects of the mGluR5 positive allosteric modulator CDPPB in the cortex and striatum following repeated administration. Neuropharmacology 62:1453-1460.
47. Passani MB, Pugliese AM, Azzurrini M, et al. (1994) Effects of DAU 6215, a novel 5-hydroxytryptamine 3 (5-HT3) antagonist on electrophysiological properties of the rat hippocampus. Br J Pharmacol 112:695-703.
48. Pehrson AL and Sanchez C (2013) Serotonergic modulation of glutamate neurotransmission as a strategy for treating depression and cognitive dysfunction. CNS Spectr 19:121-133.
49. Piguet P and Galvan M (1994) Transient and long-lasting actions of 5-HT on rat dentate gyrus neurones in vitro. J Physiol 481:629-639.
50. Pitsikas N and Borsini F (1996) Itasetron (DAU 6215) prevents agerelated memory deficits in the rat in a multiple choice avoidance task. Eur J Pharmacol 311:115-119.
51. Pitsikas N, Brambilla A and Borsini F (1994) Effect of DAU 6215, a novel 5-HT3 receptor antagonist, on scopolamine-induced amnesia in the rat in a spatial learning task. Pharmacol Biochem Behav 47:95-99.
52. Raghavachari S, Kahana MJ, Rizzuto DS, et al. (2001) Gating of human theta oscillations by a working memory task. J Neurosci 21:3175-3183.
53. Raghavachari S, Lisman JE, Tully M, et al. (2006) Theta oscillations in human cortex during a working-memory task: Evidence for local generators. J Neurophysiol 95:1630-1638.
54. Ropert N and Guy N (1991) Serotonin facilitates GABAergic transmission in the CA1 region of rat hippocampus in vitro. J Physiol 441:121-136.
55. Sanchez C, Assin KE, Artigas F. Vortioxetine, a novel antidepressant with multimodal activity: Review of preclinical and clinical data. Pharm & Ther. DOI:10.1016/j.pharmthera.2014.07.001
56. Shen RY and Andrade R (1998) 5-Hydroxytryptamine 2 receptor facilitates GABAergic neurotransmission in rat hippocampus. J Pharmacol Exp Ther 285:805-812.
57. Staubli U and Otaky N (1994) Serotonin controls the magnitude of LTP induced by theta bursts via an action on NMDA-receptor-mediated responses. Brain Res 643:10-16.
58. Staubli U and Xu FB (1995) Effects of 5-HT3 receptor antagonism on hippocampal theta rhythm, memory, and LTP induction in the freely moving rat. J Neurosci 15:2445-2452.
59. Tan H, Zhong P and Yan Z (2004) Corticotropin-releasing factor and acute stress prolongs serotonergic regulation of GABA transmission in prefrontal cortical pyramidal neurons. J Neurosci 24:5000-5008.
60. Tokarski K, Kusek M and Hess G (2011) 5-HT7 receptors modulate GABAergic transmission in rat hippocampal CA1 area. J Physiol Pharmacol 62:535-540.
61. Turner TJ, Mokler DJ and Luebke JI (2004) Calcium influx through presynaptic 5-HT3 receptors facilitates GABA release in the hippocampus: In vitro slice and synaptosome studies. Neuroscience 129:703-718.
62. Vogel V, Sanchez C and Jennum P (2002) EEG measurements by means of radiotelemetry after intracerebroventricular (ICV) cannulation in rodents. J Neurosci Methods 118:89-96.
63. West PJ, Marcy VR, Marino MJ, et al. (2009) Activation of the 5-HT (6) receptor attenuates long-term potentiation and facilitates GABAergic neurotransmission in rat hippocampus. Neuroscience 164:692-701.
64. Westrich L, Pehrson A, Zhong H, et al. (2012) In vitro and in vivo effects of the multimodal antidepressant vortioxetine (Lu AA21004) at human and rat targets (abstract). Int J Psychiatry Clin Pract 16 Suppl 1:47.
65. Wigstrom H and Gustafsson B (1983) Facilitated induction of hippocampal long-lasting potentiation during blockade of inhibition. Nature 301:603-604.
66. Young CK and McNaughton N (2009) Coupling of theta oscillations between anterior and posterior midline cortex and with the hippocampus in freely behaving rats. Cereb Cortex 19:24-40.
67. Zhou FM and Hablitz JJ (1999) Activation of serotonin receptors modulates synaptic transmission in rat cerebral cortex. J Neurophysiol 82:2989-2999